Africa July 2022. Currently, umbilical cord blood stem cells are being used to treat blood cancers, inherited blood disorders, and certain metabolic and immune disorders. These diseases are prominent in South Africa, yet access to cord blood stem cells is limited.
Dr. Yvonne Holt is Chief Medical Officer of Netcells Stem Cell Bank the largest established private umbilical cord blood bank in Africa. Dr. Holt acknowledges that great strides have been made internationally with regard to cord blood banking and stem cell treatment. However, its use is still not fully accessible in South Africa.
July is Cord Blood Awareness Month. The company aims to educate the public regarding the importance of umbilical cord blood storage and how it can save lives.
Dr. Holt explains that having access to cord blood provides an important source of stem cells, which can treat many life-threatening illnesses such as blood disorders such as Thalassaemia, sickle cell anemia, aplastic anemia; cancers such as leukemia, lymphoma, and solid tumors of childhood; metabolic and immune disorders.
The umbilical cord blood stem cells are mainly haematopoietic (blood-forming) stem cells. They are therefore used in these illnesses to create new, healthy bone marrow after chemotherapy.
Internationally, cord blood stem cells can be sourced from public banks that collect cord blood from voluntary donations. Since we dont have a local public stem cell bank in South Africa, it puts South African patients at a greater disadvantage, as bringing in cord blood units from overseas is prohibitively expensive.
In the past, the costs associated with private stem cell banking has posed a barrier. However, the launch of Netcells Community Stem Cell Bank in partnership with the South African Bone Marrow Registry (SABMR) the only bank of its kind in the country offers parents the opportunity to store their babys cord blood at a significantly reduced rate.
The cord blood unit can then be used by the family themselves. Alternatively, it can be used by someone else in the community who may need a lifesaving transplant. If the cord blood unit is utilized by someone else, then all costs associated with the storage are refunded to the family.
This will greatly improve transplant options for SAs diverse demographic, as it can be difficult to find a bone marrow stem cell match for patients of African origin given the lack of donors from these communities.
Its important to educate all South Africans regarding the importance of building a donor base that can serve all members of our community, says Dr Holt.
Alternatively, parents can choose to go the private cord blood banking route. They will pay the full price to have their babys cord unit stored exclusively for their child or familys use.
Dr. Holt says the process of collecting blood from a newborns umbilical cord, is easy and painless.
Once collected, it is tested, frozen, and stored in the cord blood bank.
Cord blood stem cells are used to replace dysfunctional blood-producing cells in bone marrow with healthy new cells. Once diseased cells are destroyed by chemotherapy and irradiation, new stem cells are transplanted into the patient to restore normal functioning of the bone marrow.
Netcells also runs a sibling cord blood donor program, called Families of Hope. It aims to improve poor and disadvantaged families access to stem cell banking. This is especially important if they have a child with a stem cell-treatable disease.
If a disadvantaged child requires a bone marrow stem cell transplant, and their mother is expecting a child from the same father, we will facilitate the collection of the cord blood, process, test and store the cord blood until it is needed for transplant in the ill sibling.
In this way, we hope to expand the opportunity to families who are faced with a life-threatening disease but cannot afford to save their babys precious stem cells at birth, she says.
The first cord blood transplant was done in the late 80s. Since then, there have been remarkable advances. In fact, there have been more than 40 000 cord blood transplants done worldwide.
Cord blood stem cells are also proving useful in new areas of regenerative medicine to potentially treat cerebral palsy, autism, and Type 1 diabetes. If the potential of stem cell research is realised, it could lead to breakthroughs in treatments for many diseases we face today.
Researchers are also continuing to look for ways to improve transplant success and toincrease the number of stem cellscollected from each cord, which could potentially reduce the costs associated with cord blood transplants in the future.
Cord blood is by no means regarded as a miracle cure. However, it provides an important source of stem cells to treat several life-threatening illnesses. It also has the potential to treat many more common diseases in the future as technology progresses.
For now, collecting your babys stem cells remains a valuable insurance policy for you and your loved ones.
For more info regarding cord blood banking, visit Next Biosciences.
Dr. Yvonne Holt
Yvonne Holt graduated from the University of the Witwatersrand in 1997 with a Bachelor in Medicine and Surgery (MBBCH Wits). Dr. Holt worked as a Medical Officer in the departments of Paediatrics and Obstetrics and Gynaecology for 4 years after graduation. She obtained a Diploma in Child Health (DCH) during this time.
In 2006, Dr. Holts interest in the fields of Obstetrics and Gynaecology, Paediatrics, and stem cell technology brought her to a new career path. She joined Next Biosciences as Medical Director.
In this capacity, Yvonne is responsible for the medical development of the stem cell program at Next Biosciences. She also highlights the benefits of this new technology. In 2011, Yvonne completed a 2 year, internationally recognized Diploma in Transfusion Medicine through the University of Bloemfontein.
See original here:
Stem Cells Are Needed To Treat Life-Threatening Diseases - Longevity LIVE - Longevity LIVE
- Overcoming Tendonitis: How Stem Cell Treatments Are Revolutionizing Athlete Rehabilitation - Medical Tourism Magazine - February 21st, 2024
- Unproven Stem Cell Treatments Offer Hope & Risks - Healthline - January 4th, 2023
- Stem Cell or Bone Marrow Transplant Side Effects - American Cancer Society - November 24th, 2022
- Stem cell: $137 million buys more clinical trials, shared labs ... - November 24th, 2022
- Stem Cells Australia | Australian research, stem cell treatments and ... - October 29th, 2022
- What is a Bone Marrow Transplant (Stem Cell Transplant)? - Cancer.Net - October 29th, 2022
- Cameron Mathison Is Undergoing Stem Cell Treatments - October 4th, 2022
- Hiltzik: A judge undermines the FDA on stem cells - Los Angeles Times - October 4th, 2022
- Mesoblast Submits New Information to FDA IND File in Response to Items in the CRL to the Remestemcel-L BLA for SR-aGVHD - GlobeNewswire - October 4th, 2022
- 15 Years of Heart - Newswise - October 4th, 2022
- QC Kinetix (The Heights) Helping Patients Heal Better from Joint Pain Through Houston Heights Sports Medicine - Yahoo Finance - October 4th, 2022
- Sources - Minnesota Timberwolves' Karl-Anthony Towns was on bed rest for days due to throat infection - ESPN - October 4th, 2022
- Innovative spaces and an expert team help Childrens Hospital New Orleans set the standard in cancer care - NOLA.com - September 25th, 2022
- Stem Cell Transplantation: What it Is, Process & Procedure - September 16th, 2022
- New stem cell therapy provides long-term brain protection against ALS - Study Finds - September 8th, 2022
- $150 Million Gift Takes Stem Cell Research to New Heights - University of California San Diego - September 8th, 2022
- Seattle biotech company is the first to receive approval to test B cell gene therapy in humans - GeekWire - September 8th, 2022
- Kite's CAR T-cell Therapy Tecartus Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia... - September 8th, 2022
- Could Stem-Cell Based Therapy Treat Type-1 Diabetes? A New Study Demonstrates the Treatments Potential - SciTechDaily - August 30th, 2022
- Orchard Therapeutics Announces Multiple Presentations at 2022 SSIEM Annual Symposium Highlighting Neurometabolic Disease Portfolio - GlobeNewswire - August 30th, 2022
- Global Cancer Stem Cells Market Estimated to Reach $1,722.7 Million by 2026 and Grow at 10.3% CAGR in the 2019 to 2026 Timeframe | [180-Pages] Report... - August 22nd, 2022
- Getting a Stem Cell or Bone Marrow Transplant - American Cancer Society - August 14th, 2022
- Stem cell therapy to be used in treatment of long COVID by Panacell Biotech - Labiotech.eu - August 14th, 2022
- Selma Blair 'Stopped Looking in the Mirror' After MS Treatments - TooFab - August 14th, 2022
- ElevateBio Announces the Formation of a New Company With George Daley, M.D., Ph.D., and Boston Childrens Hospital to Develop iPSC-Derived Allogeneic... - August 5th, 2022
- Stem Cell Hair Transplant: What Is It and When Will It Be Available? - July 11th, 2022
- Stem cell treatments and regulation - a quick guide for consumers - July 11th, 2022
- Tisch Multiple Sclerosis Research Center of New York Study Featured in BioSpace - Business Wire - July 3rd, 2022
- NorthX Biologics expands to Cell Therapy: Partnership with Alder Therapeutics and new manufacturing site on Karolinska campus - GlobeNewswire - June 22nd, 2022
- Japan's five hottest biotech companies in healthcare - Labiotech.eu - June 22nd, 2022
- Sickle cell beta thalassemia: Causes, symptoms, and treatments - Medical News Today - June 22nd, 2022
- Umoja Biopharma Presents Data on its Engineered Induced Pluripotent Stem Cell Platform at the 2022 International Society for Stem Cell Research Annual... - June 22nd, 2022
- Six Things to Know About Stem Cell Treatment - HealthTechZone - May 15th, 2022
- CU Anschutz center for cell-based therapy gets $200 million expansion - The Denver Post - May 15th, 2022
- Differentiation therapy, Hox genes and Abemaciclib Research update 13th May - Brain Tumour Research - May 15th, 2022
- Here's the No. 1 Reason to Buy Vertex Pharmaceuticals Now - The Motley Fool - May 15th, 2022
- To help cope with the world's oldest population, Japan is investing in transplanted iPS stem cells - CBS News - April 19th, 2022
- Stem cell cure for lower back pain is all in the 'hiPS' - Study Finds - April 19th, 2022
- Versant-backed startup launches with plans to broaden cell therapy's reach - BioPharma Dive - April 19th, 2022
- CAR NK-Cell Therapy Is Quickly Growing in Immunotherapy - Targeted Oncology - April 19th, 2022
- Robert Vonderheide Appointed to Second Five-Year Term as Director of the Abramson Cancer Center - U Penn - April 19th, 2022
- Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer - DocWire News - April 19th, 2022
- Is Stem Cell Therapy Right for You? - Health Essentials from Cleveland Clinic - April 6th, 2022
- Cleveland Cord Blood Center and Deverra Therapeutics Announce Agreement - PR Newswire - April 6th, 2022
- Early Treatment Matters More Than Ever in Multiple Myeloma, Kumar Says - AJMC.com Managed Markets Network - April 6th, 2022
- Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives - DocWire News - March 25th, 2022
- A Holistic Review on the Current and Future Status of Biology-Driven and Broad-Spectrum Therapeutic Options for Medulloblastoma - Cureus - March 25th, 2022
- Current Strategies and the Potential of CAR T-Cell Therapy in Relapsed and Refractory MCL - AJMC.com Managed Markets Network - March 25th, 2022
- 'I wouldn't be here': Virginia girl, celebrating 11 years in remission, credits St. Jude with saving her life - News 3 WTKR Norfolk - March 25th, 2022
- This weird mouse with a tuft of human hair could be the future of a stem cell treatment for baldness - Boing Boing - January 20th, 2022
- 5 questions facing gene therapy in 2022 - BioPharma Dive - January 20th, 2022
- How Stem Cell and Bone Marrow Transplants Are Used to ... - January 5th, 2022
- The Stem Cell Transplant Process - UChicago Medicine - January 5th, 2022
- Next Chapters: How Northern California blood recipients are doing years after donors helped save their lives - KCRA Sacramento - January 5th, 2022
- Exclusive: Ronnie Coleman on Recent Weight Gain, Current Strength, and Health Progress - BarBend - January 5th, 2022
- Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent ... - KULR-TV - November 8th, 2021
- Managing superficial pyoderma with light therapy - DVM 360 - October 28th, 2021
- New Treatments and Tips for Dealing With Blood Cancer - Curetoday.com - October 28th, 2021
- Orchard Therapeutics Outlines Comprehensive Presence at the - GlobeNewswire - October 16th, 2021
- Taking aim at the brain, Takeda strikes up cell therapy R&D alliance with Immusoft - MedCity News - October 16th, 2021
- The Impact Of Market Restrictions On The US Stem Cell Biomaterials Market - Med Device Online - October 16th, 2021
- FTC Follows Through On Prioritizing Investigations Into False Advertising In Healthcare Markets - Media, Telecoms, IT, Entertainment - United States -... - October 16th, 2021
- FDA Warns About Stem Cell Therapies | FDA - October 5th, 2021
- Anja Health Disrupts Cord Blood Banking with Heartfelt Founding Story and Ground-Breaking Mission - Digital Journal - October 5th, 2021
- Kite's Tecartus is First CAR T Therapy Approved for Adults with B-Cell ALL - Clinical OMICs News - October 5th, 2021
- Prolymphocytic Leukemia: What Is It and How Is It Treated? - Healthline - August 31st, 2021
- Researchers Gaze into Space to Envision Future of Regenerative Medicine - UPMC & Pitt Health Sciences News Blog - UPMC - August 18th, 2021
- Acute Myeloid Leukemia Treatment: What You Need to Know - Healthline - August 18th, 2021
- Study Calls for COVID-19 Vaccination in Patients With Cancer to Enable Optimal Treatment Delivery During Pandemic - OncLive - August 18th, 2021
- A Third Dose of the COVID-19 Vaccine Recommended for Some Cancer Patients With Weakened Immune Systems - On Cancer - Memorial Sloan Kettering - August 18th, 2021
- Stem cells: What they are and what they do - Mayo Clinic - June 6th, 2021
- Stem Cell Therapy for Knee Pain: What Patients Should Know - June 6th, 2021
- Study clarifies the impact of getting old on hematopoietic stem cells - Microbioz India - December 26th, 2020
- Stem Cell Therapy Shows 2-year Benefit for Progressive MS Patients in Phase 1 Trial - Multiple Sclerosis News Today - December 22nd, 2020
- New Combination Therapy Tested By Children's May Offer Hope For Leukemia Patients - WVXU - December 22nd, 2020
- Physio Logic Brings Cutting-edge Regenerative Treatments for Sport Injuries and Arthritis to New York City - PRNewswire - December 22nd, 2020
- For Patients With HMA-Resistant MDS, What Are Their Options? - AJMC.com Managed Markets Network - December 22nd, 2020
- In COVID-19 Clinical Trials, Experts from Baptist Health's Cancer Institutes Treat Patients With Mild or Severe Symptoms - Baptist Health South... - December 22nd, 2020
- SPONSORED: 12 Charities of Christmas - Anthony Nolan - The Courier - December 22nd, 2020
- California's Proposition 14: short in the arm for stem cell research - BioNews - December 14th, 2020